Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder

Status Not yet recruiting

Clinical Trial Summary

The investigators will evaluate the effects of an accelerated Transcranial Magnetic Stimulation (TMS) protocol of the left dorsolateral prefrontal cortex (DLPFC) for moderate to severe methamphetamine use disorder. This is a randomized parallel group design to assess feasibility and safety, evaluate efficacy (use, craving) and identify magnetic resonance imaging (resting state and cue craving) associated with group/outcomes.

Clinical Trial Description

In a randomized double-blind parallel-group sham-controlled design (n=20) administer a 5-day accelerated iTBS protocol (40 treatments) to the left dorsolateral prefrontal cortex during a short inpatient stay. Magnetic resonance imaging will be completed pre-post TMS and participants will be followed for 12 weeks. ;

Study Design

Related Conditions & MeSH terms

Methamphetamine Use Disorder

Clinical Trial Details

NCT number	NCT06320366
Study type	Interventional
Source	University of Colorado, Denver
Contact	Joseph T Sakai, MD
Phone	303-724-7402
Email	joseph.sakai@cuanschtz.edu
Status	Not yet recruiting
Phase	N/A
Start date	May 1, 2024
Completion date	May 31, 2028

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04178993` - Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine]	Phase 1
Completed	`NCT01982643` - Accelerated Development of Additive Pharmacotherapy Treatment for Methamphetamine Use Disorder	Phase 1/Phase 2
Completed	`NCT03078075` - Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder	Phase 3
Terminated	`NCT05711862` - The Effects of Suvorexant on Sleep, Stress, and Cue-reactivity in Methamphetamine Use Disorder	Phase 2
Recruiting	`NCT05322954` - Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder	Phase 1
Recruiting	`NCT05760807` - Intranasal Oxytocin for Methamphetamine Withdrawal in Women	N/A
Recruiting	`NCT04614584` - Mirtazapine and Methamphetamine Drug-drug Interaction Study	Phase 1
Recruiting	`NCT05558358` - Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder	Phase 1/Phase 2
Active, not recruiting	`NCT06279273` - A Study for the Risky Decision-making Deficits Among Methamphetamine Dependence Individuals and Treatment	N/A
Active, not recruiting	`NCT04907357` - rTMS for Stimulant Use Disorders	N/A
Completed	`NCT04713124` - A Telephone-delievered Intervention to Reduce Methamphetamine Use	N/A
Active, not recruiting	`NCT04791969` - Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM	Phase 2
Completed	`NCT00572234` - Bupropion in the Treatment of Methamphetamine Dependence	N/A
Terminated	`NCT03106571` - Study of Pomaglumetad and Methamphetamine	Phase 1
Recruiting	`NCT06033365` - Beginning Early and Assertive Treatment for Methamphetamine Use Disorder	N/A